{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T22:32:53Z","timestamp":1774823573730,"version":"3.50.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/ncpneuro0407","type":"journal-article","created":{"date-parts":[[2007,2,6]],"date-time":"2007-02-06T07:13:32Z","timestamp":1170746012000},"page":"95-106","source":"Crossref","is-referenced-by-count":56,"title":["Neurological manifestations in Fabry's disease"],"prefix":"10.1038","volume":"3","author":[{"given":"Anette T","family":"M\u00f8ller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troels S","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneuro0407_CR1","first-page":"2741","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"RJ Desnick","year":"1995","unstructured":"Desnick RJ et al. (1995) Fabry disease: alpha-Galactosidase A deficiency. In The Metabolic and Molecular Bases of Inherited Disease, 2741\u20132784 (Eds Scriver CR et al.) New York: McGraw Hill"},{"key":"BFncpneuro0407_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ et al. (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249\u2013254","journal-title":"JAMA"},{"key":"BFncpneuro0407_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M et al. (2006) High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 79: 31\u201340","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0407_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S et al. (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype. Kidney Int 64: 801\u2013807","journal-title":"Kidney Int"},{"key":"BFncpneuro0407_CR5","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","volume":"366","author":"A Rolfs","year":"2005","unstructured":"Rolfs A et al. (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366: 1794\u20131796","journal-title":"Lancet"},{"key":"BFncpneuro0407_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A et al. (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34: 236\u2013242","journal-title":"Eur J Clin Invest"},{"key":"BFncpneuro0407_CR7","unstructured":"Wilcox W and Wanner C (2005) Fabry RADAR 2005. The Fabry Registry Aggregate Data Annual Report 2005"},{"key":"BFncpneuro0407_CR8","unstructured":"The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff [ http:\/\/www.hgmd.org ]"},{"key":"BFncpneuro0407_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00439-005-1300-5","volume":"117","author":"F Matsuzawa","year":"2005","unstructured":"Matsuzawa F et al. (2005) Fabry disease: correlation between structural changes in alpha-galactosidase, and clinical and biochemical phenotypes. Hum Genet 117: 317\u2013328","journal-title":"Hum Genet"},{"key":"BFncpneuro0407_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"SC Garman","year":"2004","unstructured":"Garman SC and Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 337: 319\u2013335","journal-title":"J Mol Biol"},{"issue":"Suppl 2","key":"BFncpneuro0407_CR11","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1097\/01.ASN.0000015236.70757.C4","volume":"13","author":"GM Pastores","year":"2002","unstructured":"Pastores GM and Lien YH (2002) Biochemical and molecular genetic basis of Fabry disease. J Am Soc Nephrol 13 (Suppl 2): S130\u2013S133","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneuro0407_CR12","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/S0021-9258(18)61618-7","volume":"262","author":"P Lemansky","year":"1987","unstructured":"Lemansky P et al. (1987) Synthesis and processing of alpha-galactosidase A in human fibroblasts: evidence for different mutations in Fabry disease. J Biol Chem 262: 2062\u20132065","journal-title":"J Biol Chem"},{"key":"BFncpneuro0407_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1212\/WNL.32.4.347","volume":"32","author":"WJ Cable","year":"1982","unstructured":"Cable WJ et al. (1982) Fabry disease: significance of ultrastructural localization of lipid inclusions in dermal nerves. Neurology 32: 347\u2013353","journal-title":"Neurology"},{"key":"BFncpneuro0407_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/mus.880040506","volume":"4","author":"JF Pellissier","year":"1981","unstructured":"Pellissier JF et al. (1981) Morphological and biochemical changes in muscle and peripheral nerve in Fabry's disease. Muscle Nerve 4: 381\u2013387","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0407_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s004150050125","volume":"244","author":"K Toyooka","year":"1997","unstructured":"Toyooka K and Said G (1997) Nerve biopsy findings in hemizygous and heterozygous patients with Fabry's disease. J Neurol 244: 464\u2013468","journal-title":"J Neurol"},{"key":"BFncpneuro0407_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000115700","volume":"23","author":"F Gemignani","year":"1984","unstructured":"Gemignani F et al. (1984) Pathological study of the sural nerve in Fabry's disease. Eur Neurol 23: 173\u2013181","journal-title":"Eur Neurol"},{"key":"BFncpneuro0407_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ana.410230513","volume":"23","author":"EM Kaye","year":"1988","unstructured":"Kaye EM et al. (1988) Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 23: 505\u2013509","journal-title":"Ann Neurol"},{"key":"BFncpneuro0407_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF00697017","volume":"30","author":"T Tabira","year":"1974","unstructured":"Tabira T et al. (1974) Neuropathological and biochemical studies in Fabry's disease. Acta Neuropathol (Berl) 30: 345\u2013354","journal-title":"Acta Neuropathol (Berl)"},{"key":"BFncpneuro0407_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0022-510X(89)90113-5","volume":"90","author":"I Hozumi","year":"1989","unstructured":"Hozumi I et al. (1989) Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease. J Neurol Sci 90: 273\u2013280","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0407_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ana.410310410","volume":"31","author":"GA deVeber","year":"1992","unstructured":"deVeber GA et al. (1992) Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 31: 409\u2013415","journal-title":"Ann Neurol"},{"key":"BFncpneuro0407_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jmg.20.4.309","volume":"20","author":"N Gadoth","year":"1983","unstructured":"Gadoth N and Sandbank U (1983) Involvement of dorsal root ganglia in Fabry's disease. J Med Genet 20: 309\u2013312","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archneur.1978.00500290037007","volume":"35","author":"AA Sima","year":"1978","unstructured":"Sima AA and Robertson DM (1978) Involvement of peripheral nerve and muscle in Fabry's disease: histologic, ultrastructural, and morphometric studies. Arch Neurol 35: 291\u2013301","journal-title":"Arch Neurol"},{"key":"BFncpneuro0407_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00401-005-0026-8","volume":"111","author":"C Navarro","year":"2006","unstructured":"Navarro C et al. (2006) Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients. Acta Neuropathol (Berl) 111: 178\u2013185","journal-title":"Acta Neuropathol (Berl)"},{"key":"BFncpneuro0407_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0923-1811(98)00032-2","volume":"18","author":"LM Lao","year":"1998","unstructured":"Lao LM et al. (1998) The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci 18: 109\u2013117","journal-title":"J Dermatol Sci"},{"key":"BFncpneuro0407_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/mus.20130","volume":"31","author":"D Lacomis","year":"2005","unstructured":"Lacomis D et al. (2005) Neuropathy and Fabry's disease. Muscle Nerve 31: 102\u2013107","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0407_CR26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD et al. (2001) Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38: 769\u2013775","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","volume":"32","author":"J Galanos","year":"2002","unstructured":"Galanos J et al. (2002) Clinical features of Fabry's disease in Australian patients. Intern Med J 32: 575\u2013584","journal-title":"Intern Med J"},{"key":"BFncpneuro0407_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000060195","volume":"136","author":"K Wendrich","year":"2001","unstructured":"Wendrich K et al. (2001) Neurological manifestation of Fabry disease in females. Contrib Nephrol 136: 241\u2013244","journal-title":"Contrib Nephrol"},{"issue":"Suppl","key":"BFncpneuro0407_CR29","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1080\/08035320510031045","volume":"94","author":"E Schaefer","year":"2005","unstructured":"Schaefer E et al. (2005) Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey. Acta Paediatr Suppl 94 (Suppl): S87\u2013S92","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF03401671","volume":"3","author":"CM Eng","year":"1997","unstructured":"Eng CM et al. (1997) Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med 3: 174\u2013182","journal-title":"Mol Med"},{"key":"BFncpneuro0407_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W von Scheidt","year":"1991","unstructured":"von Scheidt W et al. (1991) An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 324: 395\u2013399","journal-title":"N Engl J Med"},{"key":"BFncpneuro0407_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/BF01606034","volume":"417","author":"M Elleder","year":"1990","unstructured":"Elleder M et al. (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease: report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417: 449\u2013455","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"BFncpneuro0407_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B et al. (2002) Prevalence of Anderson\u2013Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105: 1407\u20131411","journal-title":"Circulation"},{"issue":"Suppl 2","key":"BFncpneuro0407_CR34","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1023\/A:1012451320105","volume":"24","author":"RO Brady","year":"2001","unstructured":"Brady RO et al. (2001) Enzyme replacement therapy in Fabry disease. J Inherit Metab Dis 24 (Suppl 2): S18\u2013S24","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0407_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1073\/pnas.97.1.365","volume":"97","author":"R Schiffmann","year":"2000","unstructured":"Schiffmann R et al. (2000) Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 97: 365\u2013370","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0407_CR36","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","volume":"62","author":"MJ Hilz","year":"2004","unstructured":"Hilz MJ et al. (2004) Enzyme replacement therapy improves function of C-, Adelta-, and Abeta-nerve fibers in Fabry neuropathy. Neurology 62: 1066\u20131072","journal-title":"Neurology"},{"key":"BFncpneuro0407_CR37","doi-asserted-by":"publisher","first-page":"C1076","DOI":"10.1152\/ajpcell.00426.2005","volume":"290","author":"GH Yam","year":"2006","unstructured":"Yam GH et al. (2006) Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. Am J Physiol Cell Physiol 290: C1076\u2013C1082","journal-title":"Am J Physiol Cell Physiol"},{"key":"BFncpneuro0407_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/4801","volume":"5","author":"JQ Fan","year":"1999","unstructured":"Fan JQ et al. (1999) Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 5: 112\u2013115","journal-title":"Nat Med"},{"key":"BFncpneuro0407_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0076-6879(03)01069-3","volume":"363","author":"JQ Fan","year":"2003","unstructured":"Fan JQ and Ishii S (2003) Cell-based screening of active-site specific chaperone for the treatment of Fabry disease. Methods Enzymol 363: 412\u2013420","journal-title":"Methods Enzymol"},{"key":"BFncpneuro0407_CR40","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/j.1742-4658.2006.05223.x","volume":"273","author":"M Mattocks","year":"2006","unstructured":"Mattocks M et al. (2006) Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1. Cyclosporin A can lower serum and liver globotriaosyl ceramide levels in the Fabry mouse model. FEBS J 273: 2064\u20132075","journal-title":"FEBS J"},{"key":"BFncpneuro0407_CR41","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1073\/pnas.0537900100","volume":"100","author":"J Park","year":"2003","unstructured":"Park J et al. (2003) Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer. Proc Natl Acad Sci USA 100: 3450\u20133454","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0407_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","volume":"9","author":"RJ Ziegler","year":"2004","unstructured":"Ziegler RJ et al. (2004) AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice. Mol Ther 9: 231\u2013240","journal-title":"Mol Ther"},{"key":"BFncpneuro0407_CR43","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1212\/WNL.50.6.1746","volume":"50","author":"KE Crutchfield","year":"1998","unstructured":"Crutchfield KE et al. (1998) Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50: 1746\u20131749","journal-title":"Neurology"},{"key":"BFncpneuro0407_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410400105","volume":"40","author":"P Mitsias","year":"1996","unstructured":"Mitsias P and Levine SR (1996) Cerebrovascular complications of Fabry's disease. Ann Neurol 40: 8\u201317","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"BFncpneuro0407_CR45","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1080\/08035320600618908","volume":"95","author":"L Ginsberg","year":"2006","unstructured":"Ginsberg L et al. (2006) Magnetic resonance imaging changes in Fabry disease. Acta Paediatr Suppl 95 (Suppl): S57\u2013S62","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1552-6569.2001.tb00051.x","volume":"11","author":"DF Moore","year":"2001","unstructured":"Moore DF et al. (2001) Selective arterial distribution of cerebral hyperperfusion in Fabry disease. J Neuroimaging 11: 303\u2013307","journal-title":"J Neuroimaging"},{"key":"BFncpneuro0407_CR47","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1161\/01.STR.32.7.1559","volume":"32","author":"G Altarescu","year":"2001","unstructured":"Altarescu G et al. (2001) Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 32: 1559\u20131562","journal-title":"Stroke"},{"key":"BFncpneuro0407_CR48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1212\/01.wnl.0000173030.70057.eb","volume":"65","author":"A Fellgiebel","year":"2005","unstructured":"Fellgiebel A et al. (2005) White matter lesion severity in male and female patients with Fabry disease. Neurology 65: 600\u2013602","journal-title":"Neurology"},{"key":"BFncpneuro0407_CR49","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00415-006-0118-y","volume":"253","author":"A Fellgiebel","year":"2006","unstructured":"Fellgiebel A et al. (2006) Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study. J Neurol 253: 780\u2013787","journal-title":"J Neurol"},{"key":"BFncpneuro0407_CR50","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1023\/B:BOLI.0000028794.04349.91","volume":"27","author":"L Jardim","year":"2004","unstructured":"Jardim L et al. (2004) CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy. J Inherit Metab Dis 27: 229\u2013240","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl","key":"BFncpneuro0407_CR51","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1080\/08035320600619153","volume":"95","author":"EH Kolodny","year":"2006","unstructured":"Kolodny EH and Pastores GM (2006) CNS pathology and vascular\/circulatory abnormalities in Fabry disease. Acta Paediatr Suppl 95 (Suppl): S55\u2013S56","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s00415-005-0020-z","volume":"253","author":"S Marino","year":"2006","unstructured":"Marino S et al. (2006) Diffuse structural and metabolic brain changes in Fabry disease. J Neurol 253: 434\u2013440","journal-title":"J Neurol"},{"key":"BFncpneuro0407_CR53","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/hc3801.096352","volume":"104","author":"DF Moore","year":"2001","unstructured":"Moore DF et al. (2001) Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 104: 1506\u20131512","journal-title":"Circulation"},{"key":"BFncpneuro0407_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/hs0202.102601","volume":"33","author":"DF Moore","year":"2002","unstructured":"Moore DF et al. (2002) Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 33: 525\u2013531","journal-title":"Stroke"},{"key":"BFncpneuro0407_CR55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1474-4422(06)70548-8","volume":"5","author":"A Fellgiebel","year":"2006","unstructured":"Fellgiebel A et al. (2006) CNS manifestations of Fabry's disease. Lancet Neurol 5: 791\u2013795","journal-title":"Lancet Neurol"},{"key":"BFncpneuro0407_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/jnnp.61.1.62","volume":"61","author":"D Bowsher","year":"1996","unstructured":"Bowsher D (1996) Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry 61: 62\u201369","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFncpneuro0407_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(01)01303-6","volume":"429","author":"M Zimmermann","year":"2001","unstructured":"Zimmermann M (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429: 23\u201337","journal-title":"Eur J Pharmacol"},{"key":"BFncpneuro0407_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncpneuro0113","volume":"2","author":"R Baron","year":"2006","unstructured":"Baron R (2006) Mechanisms of disease: neuropathic pain\u2014a clinical perspective. Nat Clin Pract Neurol 2: 95\u2013106","journal-title":"Nat Clin Pract Neurol"},{"key":"BFncpneuro0407_CR59","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/ncpneuro0118","volume":"2","author":"NB Finnerup","year":"2006","unstructured":"Finnerup NB and Jensen TS (2006) Mechanisms of disease: mechanism-based classification of neuropathic pain\u2014a critical analysis. Nat Clin Pract Neurol 2: 107\u2013115","journal-title":"Nat Clin Pract Neurol"},{"key":"BFncpneuro0407_CR60","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","volume":"288","author":"CJ Woolf","year":"2000","unstructured":"Woolf CJ and Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288: 1765\u20131769","journal-title":"Science"},{"key":"BFncpneuro0407_CR61","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jmg.27.5.303","volume":"27","author":"L Hasholt","year":"1990","unstructured":"Hasholt L et al. (1990) A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations. J Med Genet 27: 303\u2013306","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR62","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1023\/A:1012993305223","volume":"24","author":"C Whybra","year":"2001","unstructured":"Whybra C et al. (2001) Anderson\u2013Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 24: 715\u2013724","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0407_CR63","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"PB Deegan","year":"2006","unstructured":"Deegan PB et al. (2006) Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet 43: 347\u2013352","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0304-3959(99)00236-5","volume":"84","author":"MJ Hilz","year":"2000","unstructured":"Hilz MJ et al. (2000) Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain 84: 361\u2013365","journal-title":"Pain"},{"key":"BFncpneuro0407_CR65","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","volume":"19","author":"M Dutsch","year":"2002","unstructured":"Dutsch M et al. (2002) Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol 19: 575\u2013586","journal-title":"J Clin Neurophysiol"},{"key":"BFncpneuro0407_CR66","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/mus.10236","volume":"26","author":"CA Luciano","year":"2002","unstructured":"Luciano CA et al. (2002) Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve 26: 622\u2013629","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0407_CR67","first-page":"491","volume":"75","author":"SH Morgan","year":"1990","unstructured":"Morgan SH et al. (1990) The neurological complications of Anderson\u2013Fabry disease (alpha-galactosidase A deficiency)\u2014investigation of symptomatic and presymptomatic patients. Q J Med 75: 491\u2013507","journal-title":"Q J Med"},{"key":"BFncpneuro0407_CR68","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1085-9489.2006.00076.x","volume":"11","author":"AT Moller","year":"2006","unstructured":"Moller AT et al. (2006) Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin. J Peripher Nerv Syst 11: 119\u2013125","journal-title":"J Peripher Nerv Syst"},{"key":"BFncpneuro0407_CR69","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1212\/WNL.39.4.598","volume":"39","author":"MR Filling-Katz","year":"1989","unstructured":"Filling-Katz MR et al. (1989) Carbamazepine in Fabry's disease: effective analgesia with dose-dependent exacerbation of autonomic dysfunction. Neurology 39: 598\u2013600","journal-title":"Neurology"},{"key":"BFncpneuro0407_CR70","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1025127723729","volume":"26","author":"M Ries","year":"2003","unstructured":"Ries M et al. (2003) Use of gabapentin to reduce chronic neuropathic pain in Fabry disease. J Inherit Metab Dis 26: 413\u2013414","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0407_CR71","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mus.10497","volume":"28","author":"R Schiffmann","year":"2003","unstructured":"Schiffmann R et al. (2003) Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 28: 703\u2013710","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0407_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mus.20550","volume":"34","author":"R Schiffmann","year":"2006","unstructured":"Schiffmann R et al. (2006) Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 34: 53\u201356","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0407_CR73","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1359-6446(05)03637-8","volume":"11","author":"RR Myers","year":"2006","unstructured":"Myers RR et al. (2006) The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 11: 8\u201320","journal-title":"Drug Discov Today"},{"key":"BFncpneuro0407_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0304-3959(03)00006-x","volume":"102","author":"TS Jensen","year":"2003","unstructured":"Jensen TS and Baron R (2003) Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102: 1\u20138","journal-title":"Pain"},{"key":"BFncpneuro0407_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(01)01302-4","volume":"429","author":"TS Jensen","year":"2001","unstructured":"Jensen TS et al. (2001) The clinical picture of neuropathic pain. Eur J Pharmacol 429: 1\u201311","journal-title":"Eur J Pharmacol"},{"key":"BFncpneuro0407_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(01)00188-7","volume":"95","author":"RA Newton","year":"2001","unstructured":"Newton RA et al. (2001) Dorsal root ganglion neurons show increased expression of the calcium channel alpha2delta-1 subunit following partial sciatic nerve injury. Brain Res Mol Brain Res 95: 1\u20138","journal-title":"Brain Res Mol Brain Res"},{"key":"BFncpneuro0407_CR77","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1124\/jpet.102.041574","volume":"303","author":"ZD Luo","year":"2002","unstructured":"Luo ZD et al. (2002) Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 303: 1199\u20131205","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncpneuro0407_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/neu.20094","volume":"61","author":"JN Wood","year":"2004","unstructured":"Wood JN et al. (2004) Voltage-gated sodium channels and pain pathways. J Neurobiol 61: 55\u201371","journal-title":"J Neurobiol"},{"key":"BFncpneuro0407_CR79","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","volume":"47","author":"T DeGraba","year":"2000","unstructured":"DeGraba T et al. (2000) Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol 47: 229\u2013233","journal-title":"Ann Neurol"},{"key":"BFncpneuro0407_CR80","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10545-006-0340-x","volume":"29","author":"RJ Kalliokoski","year":"2006","unstructured":"Kalliokoski RJ et al. (2006) Structural and functional changes in peripheral vasculature of Fabry patients. J Inherit Metab Dis 29: 660\u2013666","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0407_CR81","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jmg.38.9.629","volume":"38","author":"P Boutouyrie","year":"2001","unstructured":"Boutouyrie P et al. (2001) Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 38: 629\u2013631","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR82","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0021-9150(93)90088-C","volume":"102","author":"ML Bots","year":"1993","unstructured":"Bots ML et al. (1993) Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis 102: 99\u2013105","journal-title":"Atherosclerosis"},{"issue":"Suppl","key":"BFncpneuro0407_CR83","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1080\/08035320600618924","volume":"95","author":"F Barbey","year":"2006","unstructured":"Barbey F et al. (2006) Increased carotid intima\u2013media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 95 (Suppl): S63\u2013S68","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR84","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00428-005-0089-x","volume":"448","author":"R Schiffmann","year":"2006","unstructured":"Schiffmann R et al. (2006) Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch 448: 337\u2013343","journal-title":"Virchows Arch"},{"key":"BFncpneuro0407_CR85","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/01.CIR.0000154550.15963.80","volume":"111","author":"PF Bodary","year":"2005","unstructured":"Bodary PF et al. (2005) Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency. Circulation 111: 629\u2013632","journal-title":"Circulation"},{"key":"BFncpneuro0407_CR86","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0387-7604(12)80153-7","volume":"14","author":"M Inagaki","year":"1992","unstructured":"Inagaki M et al. (1992) Relative hypoxia of the extremities in Fabry disease. Brain Dev 14: 328\u2013333","journal-title":"Brain Dev"},{"issue":"Suppl","key":"BFncpneuro0407_CR87","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1111\/j.1651-2227.2002.tb03112.x","volume":"91","author":"K Demuth","year":"2002","unstructured":"Demuth K and Germain DP (2002) Endothelial markers and homocysteine in patients with classic Fabry disease. Acta Paediatr Suppl 91 (Suppl): S57\u2013S61","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR88","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.pain.2006.04.011","volume":"124","author":"PM Lang","year":"2006","unstructured":"Lang PM et al. (2006) Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease. Pain 124: 190\u2013200","journal-title":"Pain"},{"key":"BFncpneuro0407_CR89","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0304-3959(00)00286-4","volume":"87","author":"F Birklein","year":"2000","unstructured":"Birklein F et al. (2000) Experimental tissue acidosis leads to increased pain in complex regional pain syndrome (CRPS). Pain 87: 227\u2013234","journal-title":"Pain"},{"key":"BFncpneuro0407_CR90","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/brain\/114.4.1929","volume":"114","author":"H Fujimura","year":"1991","unstructured":"Fujimura H et al. (1991) Vulnerability of nerve fibres to ischaemia: a quantitative light and electron microscope study. Brain 114: 1929\u20131942","journal-title":"Brain"},{"key":"BFncpneuro0407_CR91","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0166-2236(94)90149-X","volume":"17","author":"S Bevan","year":"1994","unstructured":"Bevan S and Geppetti P (1994) Protons: small stimulants of capsaicin-sensitive sensory nerves. Trends Neurosci 17: 509\u2013512","journal-title":"Trends Neurosci"},{"key":"BFncpneuro0407_CR92","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.neuroscience.2004.02.012","volume":"125","author":"D Fu","year":"2004","unstructured":"Fu D et al. (2004) Permanent occlusion of the middle cerebral artery upregulates expression of cytokines and neuronal nitric oxide synthase in the spinal cord and urinary bladder in the adult rat. Neuroscience 125: 819\u2013831","journal-title":"Neuroscience"},{"key":"BFncpneuro0407_CR93","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neulet.2003.12.007","volume":"361","author":"C Sommer","year":"2004","unstructured":"Sommer C and Kress M (2004) Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 361: 184\u2013187","journal-title":"Neurosci Lett"},{"key":"BFncpneuro0407_CR94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pain.2005.02.010","volume":"115","author":"NM Breese","year":"2005","unstructured":"Breese NM et al. (2005) Peripheral inflammation selectively increases TRPV1 function in IB4-positive sensory neurons from adult mouse. Pain 115: 37\u201349","journal-title":"Pain"},{"key":"BFncpneuro0407_CR95","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1523\/JNEUROSCI.22-02-00536.2002","volume":"22","author":"M Schafers","year":"2002","unstructured":"Schafers M et al. (2002) Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci 22: 536\u2013545","journal-title":"J Neurosci"},{"key":"BFncpneuro0407_CR96","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/0002-8703(83)90241-7","volume":"105","author":"Y Seino","year":"1983","unstructured":"Seino Y et al. (1983) Peripheral hemodynamics in patients with Fabry's disease. Am Heart J 105: 783\u2013787","journal-title":"Am Heart J"},{"issue":"Suppl","key":"BFncpneuro0407_CR97","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1111\/j.1651-2227.2002.tb03120.x","volume":"91","author":"MF Lyon","year":"2002","unstructured":"Lyon MF (2002) X-chromosome inactivation and human genetic disease. Acta Paediatr Suppl 91 (Suppl): S107\u2013S112","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR98","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/301858","volume":"62","author":"BR Migeon","year":"1998","unstructured":"Migeon BR and Haisley-Royster C (1998) Familial skewed X inactivation and X-linked mutations: unbalanced X inactivation is a powerful means to ascertain X-linked genes that affect cell proliferation. Am J Hum Genet 62: 1555\u20131557","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0407_CR99","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-2001-15398","volume":"19","author":"I Van den Veyver","year":"2001","unstructured":"Van den Veyver I (2001) Skewed X inactivation in X-linked disorders. Semin Reprod Med 19: 183\u2013191","journal-title":"Semin Reprod Med"},{"key":"BFncpneuro0407_CR100","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1056\/NEJM199801293380611","volume":"338","author":"JM Puck","year":"1998","unstructured":"Puck JM and Willard HF (1998) X inactivation in females with X-linked disease. N Engl J Med 338: 325\u2013328","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"BFncpneuro0407_CR101","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1080\/08035320600618759","volume":"95","author":"WB Dobyns","year":"2006","unstructured":"Dobyns WB (2006) The pattern of inheritance of X-linked traits is not dominant or recessive, just X-linked. Acta Paediatr Suppl 95 (Suppl): S11\u2013S15","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR102","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/jmg.33.8.682","volume":"33","author":"I Redonnet-Vernhet","year":"1996","unstructured":"Redonnet-Vernhet I et al. (1996) Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the alpha-galactosidase A gene. J Med Genet 33: 682\u2013688","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR103","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R et al. (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes: eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med 83: 647\u2013654","journal-title":"J Mol Med"},{"key":"BFncpneuro0407_CR104","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1136\/jmg.40.8.e103","volume":"40","author":"A Morrone","year":"2003","unstructured":"Morrone A et al. (2003) Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers. J Med Genet 40: e103","journal-title":"J Med Genet"},{"issue":"Suppl","key":"BFncpneuro0407_CR105","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1080\/08035320600618809","volume":"95","author":"EM Maier","year":"2006","unstructured":"Maier EM et al. (2006) Disease manifestations and X inactivation in heterozygous females with Fabry disease. Acta Paediatr Suppl 95 (Suppl): S30\u2013S38","journal-title":"Acta Paediatr Suppl"},{"issue":"Suppl","key":"BFncpneuro0407_CR106","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1080\/08035320600618825","volume":"95","author":"M Beck","year":"2006","unstructured":"Beck M (2006) The Mainz Severity Score Index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95 (Suppl): S43\u2013S46","journal-title":"Acta Paediatr Suppl"},{"key":"BFncpneuro0407_CR107","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S1079-9796(03)00163-3","volume":"31","author":"GE Linthorst","year":"2003","unstructured":"Linthorst GE et al. (2003) Blood group does not correlate with disease severity in patients with Fabry disease (alpha-galactosidase A deficiency). Blood Cells Mol Dis 31: 324\u2013326","journal-title":"Blood Cells Mol Dis"},{"key":"BFncpneuro0407_CR108","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/01.gim.0000223545.63012.5a","volume":"8","author":"NJ Street","year":"2006","unstructured":"Street NJ et al. (2006) Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8: 346\u2013353","journal-title":"Genet Med"},{"key":"BFncpneuro0407_CR109","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD et al. (2001) Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38: 750\u2013760","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR110","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","volume":"84","author":"S Gupta","year":"2005","unstructured":"Gupta S et al. (2005) The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women. Medicine (Baltimore) 84: 261\u2013268","journal-title":"Medicine (Baltimore)"},{"key":"BFncpneuro0407_CR111","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1136\/jmg.40.4.e38","volume":"40","author":"N Guffon","year":"2003","unstructured":"Guffon N (2003) Clinical presentation in female patients with Fabry disease. J Med Genet 40: e38","journal-title":"J Med Genet"},{"key":"BFncpneuro0407_CR112","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1479-7364-2-5-297","volume":"2","author":"J Shabbeer","year":"2006","unstructured":"Shabbeer J et al. (2006) Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations. Hum Genomics 2: 297\u2013309","journal-title":"Hum Genomics"},{"issue":"Suppl 2","key":"BFncpneuro0407_CR113","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1023\/A:1012447102358","volume":"24","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD et al. (2001) Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis 24 (Suppl 2): S13\u2013S14","journal-title":"J Inherit Metab Dis"},{"key":"BFncpneuro0407_CR114","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1212\/WNL.52.6.1249","volume":"52","author":"LJ Scott","year":"1999","unstructured":"Scott LJ et al. (1999) Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52: 1249\u20131254","journal-title":"Neurology"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0407","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneuro0407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:28:44Z","timestamp":1684441724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BFncpneuro0407"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0407","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}